Eotaxin Level in Induced Sputum Is Increased in Patients with Bronchial Asthma and in Smokers
- 1 December 2003
- journal article
- research article
- Published by S. Karger AG in Respiration
- Vol. 70 (6) , 600-605
- https://doi.org/10.1159/000075205
Abstract
Background: Airway eosinophilia is one of the hallmarks of asthma. Eotaxin may play an important role in eosinophil recruitment. Objectives: To examine the relationship between eotaxin levels in the sputum and eosinophilic inflammation. Methods: The sputum was obtained from 11 non-smokers, 14 smokers and 13 asthmatic patients using a sputum induction method. Eotaxin and interleukin (IL)-5 levels in the sputum were determined by ELISA and immunocytochemical analysis. Results: Asthmatic patients had eosinophilia and smokers showed neutrophilia in their sputum. The eotaxin level in the sputum was significantly higher in smokers (median 412.5, range 91.1–872.2 pg/ml) and asthmatic patients (351.0, 185.0–928.0 pg/ml) compared with non-smokers (123.2, 0–369.0 pg/ml; both p < 0.05). IL-5 was detected in the sputum of 1 non-smoker, none of the smokers and 4 asthmatic patients. The percentage of eotaxin-positive cells was higher in smokers and asthmatic patients than in non-smokers, but the percentage of IL-5-positive cells was significantly higher only in asthmatic patients (p < 0.05). Conclusions: These findings suggest that the elevated eotaxin level in the sputum does not always accompany the increase in eosinophils, and cooperation with another cytokine such as IL-5 may be required for the recruitment of eosinophils.Keywords
This publication has 9 references indexed in Scilit:
- Effects of tobacco smoke on the secretion of interleukin‐1β, tumor necrosis factor‐α, and transforming growth factor‐β from peripheral blood mononuclear cellsOral Microbiology and Immunology, 2002
- Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmaticsAllergy, 2002
- The trials and tribulations of IL-5, eosinophils, and allergic asthmaJournal of Allergy and Clinical Immunology, 2001
- Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic responsePublished by Elsevier ,2001
- Increases in eotaxin‐positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challengeAllergy, 1999
- INTERLEUKIN 5 RELEASE INTO ASTHMATIC AIRWAYS 4 AND 24HOURS AFTER ENDOBRONCHIAL ALLERGEN CHALLENGE: ITS RELATIONSHIP WITH EOSINOPHIL RECRUITMENTCytokine, 1999
- Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalationClinical and Experimental Immunology, 1998
- Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophiliaNature Medicine, 1996
- Eotaxin: Cloning of an Eosinophil Chemoattractant Cytokine and Increased mRNA Expression in Allergen-Challenged Guinea-Pig LungsBiochemical and Biophysical Research Communications, 1994